IGF1 and sudden sensorineural hearing loss: Nakagawa et al. have previously demonstrated the superiority of the topical application of IGF-1 to the round window niche using a sustained-release hydrogel in patients with sudden deafness who do not respond to systemic administration of corticosteroids [37].